Aim A Quality improvement Initiative to see the rate and trend of Catheter Related Blood Stream Infections (CBRSI) using a passive disinfection device in babies admitted to tertiary neonatal unit by eliminating variation of active disinfection in clinical practice both in terms of duration and effectiveness.
Method We used Curos® port protector (Vygon UK Ltd), a disposable passive disinfection device, from Dec 2014 to July 2015 in babies admitted to the intensive care and high dependency rooms of the neonatal intensive care unit. Baseline data of existing CRBSI rate from last 3 years was available. Daily compliance audits were conducted initially for the first 4 weeks for the new clinical practice to become embedded and then weekly afterwards. The aim was to achieve minimum compliance of 85% for data to be included based on data which suggested a minimum of 80% was required for full efficacy.
The study was supported by Vygon who provided the device for half price during the intervention and agreed for a refund on costs if no reduction in CBRSI was seen.
Results 95% patient and IV port access compliance was achieved. (Graph 1). CRBSI was defined as a baby with central line in situ and a positive blood culture and calculated per 1000 central line days. We did not find a decline in the rate of CRBSI in our unit with the introduction of Curos® port protectors. Further when we collected data for 3 months post Curos® project, the rate of CRBSI stayed similar to the pre and study periods. (Table 1) (Figure 2)
Conclusion The use of Curos port protector as a passive disinfection device did not reduce the rate of catheter related blood stream infections in our tertiary neonatal unit.
The cost saving of this is £6000 per year.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.